March 01, 2021 Early Morphic data hint at a threat to Entyvio Hopes rise that Morphic might have cracked the conundrum of oral integrin inhibitors.
July 02, 2019 Back to business for biotech flotations After a quiet first quarter demand for new issues has returned to levels seen in 2018, itself a record year for IPOs of young drug developers.
August 31, 2017 Corporate venture firms – dedicated followers of fashion? Eagerly pursuing all the latest fads and trends.
